JP Patent

JP7579684B2 — ７－ベンジル－４－（２－メチルベンジル）－２，４，６，７，８，９－ヘキサヒドロイミダゾ［１，２－ａ］ピリド［３，４－ｅ］ピリミジン－５（１ｈ）－オン、その類似体、およびこれらの塩ならびに治療におけるこれらの使用方法

Assigned to Oncoceutics Inc · Expires 2024-11-08 · 2y expired

What this patent protects

Patent listed against dordaviprone-hydrochloride.

Drugs covered by this patent

dordaviprone-hydrochloride (DORDAVIPRONE HYDROCHLORIDE)

Patent Metadata

Patent number: JP7579684B2
Jurisdiction: JP
Classification: —
Expires: 2024-11-08
Drug substance claim: No
Drug product claim: No
Assignee: Oncoceutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.